518.81
1.35%
-7.11
Mckesson Corporation stock is currently priced at $518.81, with a 24-hour trading volume of 623.94K.
It has seen a -1.35% decreased in the last 24 hours and a -2.06% declined in the past month.
The chart indicates a potential bearish trend, as the stock is below the $527.4 pivot point. If it approaches the $515.1 support level, significant changes may occur.
Mckesson Corporation Stock (MCK) Financials Data
Mckesson Corporation (MCK) Revenue 2024
MCK reported a revenue (TTM) of $301.51 billion for the quarter ending December 31, 2023, a +10.08% rise year-over-year.
Mckesson Corporation (MCK) Net Income 2024
MCK net income (TTM) was -$10.74 million for the quarter ending December 31, 2023, a +18.44% increase year-over-year.
Mckesson Corporation (MCK) Cash Flow 2024
MCK recorded a free cash flow (TTM) of $2.89 billion for the quarter ending December 31, 2023, a -30.98% decrease year-over-year.
Mckesson Corporation (MCK) Earnings per Share 2024
MCK earnings per share (TTM) was -$1.08 for the quarter ending December 31, 2023, a +40.33% growth year-over-year.
Mckesson Corporation Stock (MCK) Insider Trading
Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
---|---|---|---|---|---|---|---|
TYLER BRIAN S. | Chief Executive Officer |
Mar 15 '24 |
Option Exercise |
159.00 |
3,473 |
552,207 |
46,918 |
TYLER BRIAN S. | Chief Executive Officer |
Mar 15 '24 |
Sale |
524.55 |
3,473 |
1,821,762 |
43,445 |
Rutledge Napoleon B JR | SVP, Controller & CAO |
Mar 04 '24 |
Sale |
529.99 |
190 |
100,698 |
887 |
Rutledge Napoleon B JR | SVP, Controller & CAO |
Mar 01 '24 |
Option Exercise |
0.00 |
785 |
0 |
1,260 |
Smith LeAnn B | EVP & Chief HR Officer |
Feb 13 '24 |
Sale |
496.00 |
186 |
92,256 |
1,511 |
Smith LeAnn B | EVP & Chief HR Officer |
Feb 10 '24 |
Option Exercise |
0.00 |
507 |
0 |
1,832 |
TYLER BRIAN S. | Chief Executive Officer |
Jan 03 '24 |
Option Exercise |
138.73 |
14,026 |
1,945,896 |
53,563 |
TYLER BRIAN S. | Chief Executive Officer |
Jan 03 '24 |
Sale |
480.00 |
14,026 |
6,732,480 |
43,445 |
TYLER BRIAN S. | Chief Executive Officer |
Nov 07 '23 |
Sale |
457.51 |
23,963 |
10,963,281 |
43,445 |
Smith LeAnn B | EVP & Chief HR Officer |
Nov 03 '23 |
Sale |
461.26 |
660 |
304,432 |
1,325 |
Mckesson Corporation Stock (MCK) Latest News
Strength Seen in Staar Surgical (STAA): Can Its 16.5% Jump Turn into More Strength?
Zacks Investment Research
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
Zacks Investment Research
The Zacks Analyst Blog Highlights Apple, NVIDIA, Eli Lilly, American Tower and McKesson
Zacks Investment Research
Top Stock Reports for Apple, NVIDIA & Eli Lilly
Zacks Investment Research
Here's Why McKesson (MCK) is a Strong Value Stock
Zacks Investment Research
McKesson (MCK) Hits 52-Week High: What's Driving the Stock?
Zacks Investment Research
About Mckesson Corporation
McKesson Corporation provides pharmaceuticals and medical supplies in the United States and internationally. It operates in three segments: U.S. Pharmaceutical and Specialty Solutions, European Pharmaceutical Solutions, and Medical-Surgical Solutions. The company distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs, as well as other healthcare-related products; and offers practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices. It also provides specialty pharmaceutical solutions for pharmaceutical manufacturers; and medical-surgical supply distribution, logistics, and other services to healthcare providers. In addition, the company operates retail pharmacy chains in Europe and Canada, as well as supports independent pharmacy networks within North America and Europe; and supplies integrated pharmacy management systems, automated dispensing systems, and related services to retail, outpatient, central fill, specialty, and mail order pharmacies. Further, it provides software and analytics, network solutions, and technology-enabled services. The company serves retail national accounts, including national and regional chains, food and drug combinations, mail order pharmacies, and mass merchandisers; independent retail pharmacies; and institutional healthcare providers, such as hospitals, health systems, integrated delivery networks, and long-term care providers, as well as pharmaceutical manufacturers. McKesson Corporation was founded in 1833 and is headquartered in San Francisco, California.
Cap:
|
Volume (24h):